Silymarin in the prevention and treatment of liver diseases and primary liver cancer.
about
Identification of isosilybin a from milk thistle seeds as an agonist of peroxisome proliferator-activated receptor gammaSilymarin as a Natural Antioxidant: An Overview of the Current Evidence and PerspectivesCurrent Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future ProspectsSilymarin reduces profibrogenic cytokines and reverses hepatic fibrosis in chronic murine schistosomiasis.Hepatitis B Virus Pre-S2 Mutant Induces Aerobic Glycolysis through Mammalian Target of Rapamycin Signal Cascade.Silymarin Accelerates Liver Regeneration after Partial HepatectomyExosomes derived from human menstrual blood-derived stem cells alleviate fulminant hepatic failureOxidative stress and liver disease.Hepatoprotective effects of mushrooms.Evaluating the safety and efficacy of silymarin in β-thalassemia patients: a review.New Aspects of Silibinin Stereoisomers and their 3-O-galloyl Derivatives on Cytotoxicity and Ceramide Metabolism in Hep G2 hepatocarcinoma Cell Line.Complete regression following sorafenib in unresectable, locally advanced hepatocellular carcinoma.The expression of ETAR in liver cirrhosis and liver cancer.Effect of silymarin in the prevention of Cisplatin nephrotoxicity, a clinical trial studyA biphasic response pattern of lipid metabolomics in the stage progression of hepatitis B virus X tumorigenesis.Hepatoprotective Effect of Silymarin (Silybum marianum) on Hepatotoxicity Induced by Acetaminophen in Spontaneously Hypertensive Rats.Bone marrow-derived mesenchymal stem cells effectively regenerate fibrotic liver in bile duct ligation rat model.Silymarin effect on amyloid-β plaque accumulation and gene expression of APP in an Alzheimer's disease rat model.Null anticarcinogenic effect of silymarin on diethylnitrosamine-induced hepatocarcinogenesis in ratsSelf-nanoemulsifying drug delivery systems ameliorate the oral delivery of silymarin in rats with Roux-en-Y gastric bypass surgeryThe Impact of Silymarin on Improvement of Hepatic Abnormalities in Patients with Severe Preeclampsia: A Randomized Clinical Trial.Sesamol loaded solid lipid nanoparticles: a promising intervention for control of carbon tetrachloride induced hepatotoxicity.Beneficial effects of silibinin against the progression of metabolic syndrome, increased oxidative stress, and liver steatosis in Psammomys obesus, a relevant animal model of human obesity and diabetes.Silymarin decreases connective tissue growth factor to improve liver fibrosis in rats treated with carbon tetrachloride.Effect of Oral Silymarin Administration on Prevention of Radiotherapy Induced Mucositis: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.Topical Silymarin Administration for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.Attenuation of carbon tetrachloride-induced hepatic injury with curcumin-loaded solid lipid nanoparticles.Silymarin attenuates airway inflammation induced by cigarette smoke in mice.Effects of lactulose and silymarin on liver enzymes in cirrhotic rats.Modulation ofTinospora rumphiiand Zinc Salt on DNA Damage in Quinoline-Induced Genotoxicity and Hepatotoxicity in Male Albino Mice
P2860
Q24567657-198B2552-AD7E-4BC4-BC59-3997D6F10BCDQ26770933-53D82322-DE9F-4A53-AEDA-1E3BB9B5700EQ26775055-4C48A271-5723-4FB7-A5F8-28F69C76EEAEQ33622760-60F06490-9E06-4EBE-8B4E-3F264FF2E298Q35536490-0CEC99C1-A59B-476C-82A6-AD35633079FCQ35962716-9F978A99-6CA3-4ADD-9655-F50829CC88DDQ37602609-175DBE43-D0F6-4363-A4C0-E1D8E27761E5Q38001458-15A0DB24-E1D6-4301-8047-CA163982177EQ38123952-C9E107A9-8DD7-4141-A50C-6CCEC913B135Q38341299-C0B5BC16-2303-420D-8938-904046DB65D9Q38726003-13988694-0293-47C6-A861-27EE8D583EB2Q39374939-9CEE4AC0-0959-41ED-BCFD-80F4DCD25106Q40091697-A14B24F0-6A7B-4BDB-809F-58A3962B5BADQ40831749-7B94212A-9B6C-4139-B0FF-9F7358CEBE5AQ41540811-D80B47EC-DDF2-44A8-819C-F37C17E0A6DEQ41851695-BC80908A-CAA7-46C4-8DEE-3C34D31FA7D2Q41883045-DF81EC37-8CC7-450B-A50A-1AE0AF03D356Q41895176-B5171151-8489-4DFA-945B-F6AF8934B3A0Q41918847-6E50B2A8-D6AB-4943-9AC9-15ACD8410D8AQ41969540-A98E770C-95F4-42FB-A734-A3777DC72033Q42110571-9E0C0BA8-88DA-44C9-853E-8A9A674BAC60Q42207073-0A506C16-23CA-45C3-A26E-F99993826FC5Q43427762-3E29043F-86AC-4B69-9625-97FCE477CEBFQ43542076-ABB23719-4327-4FA7-9AD1-62BDC2489E85Q47640131-0D6B8693-18BB-4AF1-A230-0F3B9870305BQ48246851-E7752F9D-2B4B-404F-8A7B-E5EB9E591F14Q48345993-2EB361C1-E200-4A82-9FD5-B14DF5A0A473Q51704374-7CB9A10C-0F9C-4E79-BAA4-6849B720304BQ54447129-D0561B0C-99DA-4494-9730-424D941A4D0BQ59048878-FD6D00A9-8814-4255-8C68-04B5652CB7CB
P2860
Silymarin in the prevention and treatment of liver diseases and primary liver cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Silymarin in the prevention and treatment of liver diseases and primary liver cancer.
@en
Silymarin in the prevention and treatment of liver diseases and primary liver cancer.
@nl
type
label
Silymarin in the prevention and treatment of liver diseases and primary liver cancer.
@en
Silymarin in the prevention and treatment of liver diseases and primary liver cancer.
@nl
prefLabel
Silymarin in the prevention and treatment of liver diseases and primary liver cancer.
@en
Silymarin in the prevention and treatment of liver diseases and primary liver cancer.
@nl
P1476
Silymarin in the prevention and treatment of liver diseases and primary liver cancer.
@en
P2093
Gabriella Lengyel
János Féher
P304
P356
10.2174/138920112798868818
P577
2012-01-01T00:00:00Z